The Significance Of Troponin Elevation In Atrial Fibrillation.

Cardiac troponin assays have provided a significant contribution for the early diagnosis of cardiovascular events. There is significant evidence about the association between the absolute value of elevated cardiac troponin levels with the prognosis of patients with chest pain. However, it is well-known that elevated cardiac troponin levels may occur in situations other than acute coronary syndromes, as it happens with atrial fibrillation. The significance and prognosis of this elevation are not entirely clear. We review the evidence about the meaning of such elevation in the setting of atrial fibrillation.

[1]  D. Atar,et al.  Role of troponin I proteolysis in the pathogenesis of stunned myocardium. , 1997, Circulation research.

[2]  L. Kedes,et al.  Cloning, structural analysis, and expression of the human slow twitch skeletal muscle/cardiac troponin C gene. , 1990, The Journal of biological chemistry.

[3]  Michael Freese,et al.  Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. , 2011, European heart journal.

[4]  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS The Task Force for the management of atrial fibrillation of the European Society of Cardiology ( ESC ) Developed with the special contribution of the Europ , 2016 .

[5]  J. Canty,et al.  Preload Induces Troponin I Degradation Independently of Myocardial Ischemia , 2001, Circulation.

[6]  R. Spahr,et al.  Ultrastructure of cultured adult myocardial cells during anoxia and reoxygenation. , 1984, The American journal of pathology.

[7]  G Butler-Browne,et al.  Molecular cloning of human cardiac troponin I using polymerase chain reaction , 1990, FEBS letters.

[8]  D. Atsma,et al.  Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation , 2007, Pflügers Archiv - European Journal of Physiology.

[9]  E. Novak,et al.  Use of Biomarkers to Predict Readmission for Congestive Heart Failure. , 2017, The American journal of cardiology.

[10]  D. Newby,et al.  High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease , 2016, Journal of the American College of Cardiology.

[11]  L. Jordaens,et al.  Minor elevations in troponin I are associated with mortality and adverse cardiac events in patients with atrial fibrillation. , 2011, European heart journal.

[12]  K. Phan,et al.  Atrial fibrillation: review of current treatment strategies. , 2016, Journal of thoracic disease.

[13]  P. O’Rourke,et al.  Predictors of significant coronary artery disease in atrial fibrillation: Are cardiac troponins a useful measure. , 2016, International journal of cardiology.

[14]  A. Parwani,et al.  Atrial fibrillation-induced cardiac troponin I release. , 2014, International journal of cardiology.

[15]  A. Jaffe,et al.  Troponin: the biomarker of choice for the detection of cardiac injury , 2005, Canadian Medical Association Journal.

[16]  A. Jaffe,et al.  High-sensitive troponin T measurements: what do we gain and what are the challenges? , 2012, European heart journal.

[17]  B. Pau,et al.  New monoclonal antibodies as probes for human cardiac troponin I: epitopic analysis with synthetic peptides. , 1992, Molecular immunology.

[18]  D. Redfearn,et al.  Supraventricular tachycardia promotes release of troponin I in patients with normal coronary arteries. , 2005, International journal of cardiology.

[19]  T. Buchler,et al.  Current applications of cardiac troponin T for the diagnosis of myocardial damage. , 2013, Advances in clinical chemistry.

[20]  J. M. Vergara,et al.  High‐Sensitivity Cardiac Troponin Levels in Supraventricular Tachyarrhythmias , 2016, Pacing and clinical electrophysiology : PACE.

[21]  S. Manzano-Fernández,et al.  High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation , 2012, Journal of thrombosis and haemostasis : JTH.

[22]  C. Hamm,et al.  Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. , 2011, American heart journal.

[23]  Samuel Bernard,et al.  Evidence for Cardiomyocyte Renewal in Humans , 2008, Science.

[24]  A. Tveit,et al.  Improved Rate Control Reduces Cardiac Troponin T Levels in Permanent Atrial Fibrillation , 2014, Clinical cardiology.

[25]  H. White.  Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? , 2011, Journal of the American College of Cardiology.

[26]  D. Atar,et al.  High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin. , 2014, Journal of the American College of Cardiology.

[27]  J. Cigarroa,et al.  Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study. , 2011, Journal of the American College of Cardiology.

[28]  G. Gensini,et al.  Coronary atherosclerosis and adverse outcomes in patients with recent-onset atrial fibrillation and troponin rise. , 2015, The American journal of emergency medicine.